Diagnostic and therapeutic odyssey : essays in health economics
Cette thèse de doctorat met l’emphase sur les défis rencontrés par les patients atteints de maladies rares. Elle est structurée en trois parties, chacune d’entre elles dédiée aux enjeux d’un acteur au cœur de l’Odyssée diagnostique et thérapeutique des patients atteints de maladies rares. La premièr...
Main Author: | Raïs Ali, Setti |
---|---|
Other Authors: | Paris 1 |
Language: | en |
Published: |
2019
|
Subjects: | |
Online Access: | http://www.theses.fr/2019PA01E019/document |
Similar Items
-
Evaluating health policy and legal responses : how to reduce barriers and improve access to orphan drugs for rare diseases in Canada
by: Blais, Catherine-Marie
Published: (2016) -
Analysis of patient access to orphan drugs in Turkey
by: Güvenç Koçkaya, et al.
Published: (2021-02-01) -
Using four decades of FDA orphan drug designations to describe trends in rare disease drug development: substantial growth seen in development of drugs for rare oncologic, neurologic, and pediatric-onset diseases
by: Kathleen L. Miller, et al.
Published: (2021-06-01) -
European and Italian regulation on orphan medicinal products
by: Roberta Joppi
Published: (2013-03-01) -
The work, goals, challenges, achievements, and recommendations of orphan medicinal product organizations in India: an interview-based study
by: Mohua Chakraborty Choudhury, et al.
Published: (2019-11-01)